View
62
Download
1
Category
Tags:
Preview:
DESCRIPTION
Cell-based hemostasis vs. platelet-based hemostasis. http://www.akh-wien.ac.at/biomed-research/htx/platweb1.htm. http://www.akh-wien.ac.at/biomed-research/htx/platweb1.htm. Asimetría de fosfolípidos de la membrana celular Actividad procoagulante de las plaquetas. Macrófago. Protrombina. - PowerPoint PPT Presentation
Citation preview
Cell-based hemostasis vs. platelet-based hemostasis
http://www.akh-wien.ac.at/biomed-research/htx/platweb1.htm
http://www.akh-wien.ac.at/biomed-research/htx/platweb1.htm
Asimetría de fosfolípidos de la membrana celularActividad procoagulante de las plaquetas
EscramblasaEscramblasa TranslocasaTranslocasa FlopasaFlopasa
ProtrombinaProtrombina
TrombinaTrombina
MacrófagoMacrófago
VesículaVesícula
CalpaínaCalpaína
CitoesqueletCitoesqueletoo
Hemophilia
Coagulation
Figure 1
A
200 bp
600 bp
B
200 bp
600 bp
200 bp
600 bp
C
2000 bp
1500 bp
2000 bp
CD14β-actin
TF GPIbβ-acti
n
CD14TF GPIb
Non-stimulated PBMC
PBMC +TRAP
Non-stimulated platelets
TRAP-stimulated platelets
Non-stimulated PBMC
LPS-stimulated PBMC
β-actin
CD14TF GPIb
β-actinCD14
TF GPIb
β-actin
CD14TF GPIb
β-actin
TF
1 2 3 4 5
47 kDa
A
IgG Basal 30 60 90 min min min
B
47 kDa
37 kDa
64.2 kDa
83 kDa
1 2 3 4
Basal 30 60 90 min min min
1 2 3 4 5
47 kDa
A
IgG Basal 30 60 90 min min min
B
47 kDa
37 kDa
64.2 kDa
83 kDa
1 2 3 4
Basal 30 60 90 min min min
Figure 2
1 2 3 4 5
47 kDa
A
IgG Basal 30 60 90 min min min
B
47 kDa
37 kDa
64.2 kDa
83 kDa
1 2 3 4
Basal 30 60 90 min min min
A 60.4 kDa 47.2 kDa
35 kDa
TRAP – – + +Puromycin – + – +
Figure 3-S
7,5 mPearson Coeff. : 0.1855
Pearson Coeff. : 0.3188
Figure 3
7,5 m
TF GPIb Merge
62.0 kDa
47.5 kDa
32.5 kDa
1 2 3 4
TRAP – – + +Puromycin – + – +
1 2 3 4 5 6 7 8
TRAP – + – + – + – +Tunicamycin – – + + – – + +Puromycin – – – – + + – –
LPS – + + – + +Puromycin – + – – – +
109. 5 kDa
78.9 kDa
60.4 kDa
47.2 kDa
35.1 kDa
24.9 kDa
109.5 kDa
1 2 3 4 5 6
78.9 kDa
60.4 kDa47.2 kDa
35.1 kDa
24.9 kDa
Figure 4
*
A. Platelets B. Platelets
C. PBMC suspensions
62.0 kDa
47.5 kDa
32.5 kDa
1 2 3 4
TRAP – – + +Puromycin – + – +
1 2 3 4 5 6 7 8
TRAP – + – + – + – +Tunicamycin – – + + – – + +Puromycin – – – – + + – –
LPS – + + – + +Puromycin – + – – – +
109. 5 kDa
78.9 kDa
60.4 kDa
47.2 kDa
35.1 kDa
24.9 kDa
109.5 kDa
1 2 3 4 5 6
78.9 kDa
60.4 kDa47.2 kDa
35.1 kDa
24.9 kDa
Figure 4
B. Platelets
*
1 2 3 4
62.0 kDa
47.5 kDa32.5 kDa
LPS + + + + Actinomycin D – + – – DRB – – + –Puromycin – – – +
Figure 4S
MergeGPIbαTF
3 m
Hoechst Vis
Figure 5
Merge
GPIb
GPIb
TF
TF
VisTF GPIbα
TF GPIbα Merge
Figure 5-S
TFGPIb
Merge
GPIbα TF
Merge
GPIbα TF
Merge
Figure 6
GPIbα TF
Merge
6 μM
0 25 50 75 100 1250
10
20
30 DMSOPuromycin
Time (minutes)
Proc
oagu
lant
act
ivity
(AU
/ 2x
107 p
late
lets
)
0 25 50 75 100 1250
10
20
30 DMSOPuromycin
Time (minutes)
Proc
oagu
lant
act
ivity
(AU
/ 2x
107 p
late
lets
)
Figure 1-S
0 15 60 1200
50
100
150
200
250
Control
aPC
CTI
-FVIII:C-TF
-FVIIa
Time (min)Activation with 5M TRAP
Proc
oagu
lant
Act
ivity
(%)
Figure 2-S
Regular ManuscriptHuman platelets synthesize and express functional tissue factor.
Olga Panes1, Valeria Matus1, Claudia G. Sáez1, Teresa Quiroga2, Jaime Pereira1, Diego Mezzano1.
From the Departments of Hematology-Oncology1, and Clinical Laboratory2, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Supported by Grants 8010002 (D.M., J.P., T.Q.) and 1060637 (D.M.) from Fondecyt, Chile.
(Blood, 2007, en prensa)
Recommended